ArriVent BioPharma, Inc. Common Stock (AVBP)
AVBP Stock Price Chart
Explore ArriVent BioPharma, Inc. Common Stock interactive price chart. Choose custom timeframes to analyze AVBP price movements and trends.
AVBP Company Profile
Discover essential business fundamentals and corporate details for ArriVent BioPharma, Inc. Common Stock (AVBP) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
26 Jan 2024
Employees
52.00
Website
https://www.arrivent.comCEO
Zhengbin Yao
Description
ArriVent BioPharma, Inc. operates as a clinical-stage biopharmaceutical company that engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers. It also engages in the development and commercialization of targeted cancer therapies for non-small-cell lung cancer (NSCLC) and other solid tumors. The company develops Furmonertinib, an epidermal growth factor receptor mutant-selective tyrosine kinase inhibitor that is in phase 3 clinical trial for the treatment of NSCLC patients; and ARR-002. It has strategic collaborations with Aarvik Therapeutics Inc. The company was incorporated in 2021 and is based in Newtown Square, Pennsylvania.
AVBP Financial Timeline
Browse a chronological timeline of ArriVent BioPharma, Inc. Common Stock corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 13 Nov 2025
EPS estimate is -$0.75.
Earnings released on 11 Aug 2025
EPS came in at -$0.90 falling short of the estimated -$0.70 by -28.57%.
Earnings released on 12 May 2025
EPS came in at -$1.90 falling short of the estimated -$0.66 by -187.88%.
Earnings released on 3 Mar 2025
EPS came in at -$0.60 surpassing the estimated -$0.78 by +23.08%.
Earnings released on 14 Nov 2024
EPS came in at -$0.61 surpassing the estimated -$0.82 by +25.61%.
Earnings released on 14 Aug 2024
EPS came in at -$0.65 matching the estimated -$0.65.
Earnings released on 8 May 2024
EPS came in at -$0.70 surpassing the estimated -$0.84 by +16.67%.
Earnings released on 26 Jan 2024
EPS came in at -$0.70 surpassing the estimated -$1.10 by +36.36%.
Earnings released on 30 Sept 2023
EPS came in at -$0.43 .
Earnings released on 30 Jun 2023
EPS came in at -$0.64 .
Earnings released on 31 Mar 2023
EPS came in at -$0.36 .
Earnings released on 30 Dec 2022
EPS came in at -$0.31 .
Earnings released on 29 Sept 2022
EPS came in at -$0.35 .
Earnings released on 30 Jun 2022
EPS came in at -$5.76 .
Earnings released on 31 Mar 2022
EPS came in at -$5.76 .
AVBP Stock Performance
Access detailed AVBP performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.